Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

About CVI Pharmaceuticals

Developer of synthetic plant-derived compounds for treating hyperlipidemia-associated maladies. The company's products are small molecule derivatives of natural products from medicinal plants. They are being developed to treat cardiovascular disease, hepatic steatosis, metabolic syndrome as well as for lowering LDL cholesterol.

CVI Pharmaceuticals Headquarter Location

4030 Fabian Way

Palo Alto, California, 94303,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.